Priority Date: 26.10.11 (US 201161551774P)

HIV PROTEASE INHIBITORS

  • Application ID: EP12843729
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
4 offices
Technology Company
no operation time available
7 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Merck & Co. Inc. and Merck Sharp & Dohme Ltd. are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 220 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 26.10.2011 - Priority Date (US 201161551774P)
  • 02.05.2013 - Publication A1 (WO2013059928)
  • 03.09.2014 - Publication A1 (EP2771332)
  • 29.06.2016 - Publication B1 (EP2771332)